{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:02:50Z","timestamp":1794013370867,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018353","name":"European Crohn's and Colitis Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.eclinm.2023.102045","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T13:26:29Z","timestamp":1688563589000},"page":"102045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy alone for Crohn's perianal fistulas (PISA-II): long-term outcomes of an international, multicentre patient preference, randomised controlled trial"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-228X","authenticated-orcid":false,"given":"Elise M.","family":"Meima - van Praag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte A.J.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra L.","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin A.T.G.M.","family":"Wasmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-3784","authenticated-orcid":false,"given":"Jaap","family":"Stoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert R.A.M.","family":"D'Haens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyriel Y.","family":"Ponsioen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina B.","family":"Gecse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel G.W.","family":"Dijkgraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1493-1768","authenticated-orcid":false,"given":"Antonino","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Bemelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne J.","family":"Buskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.eclinm.2023.102045_bib1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/ecco-jcc\/jjaa004","article-title":"Treatment of perianal fistulas in crohn's disease, seton versus anti-TNF versus surgical closure following anti-TNF [PISA]: a randomised controlled trial","volume":"14","author":"Wasmann","year":"2020","journal-title":"Journal of Crohn's & colitis"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102045_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S2468-1253(22)00088-7","article-title":"Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn\u2019s disease (PISA-II): a patient preference randomised trial","volume":"7","author":"Meima-van Praag","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102045_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"Journal of Crohn's & colitis"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102045_bib4","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/ibd.21940","article-title":"Long-term MRI-guided combined anti-TNF-\u03b1 and thiopurine therapy for Crohn's perianal fistulas","volume":"18","author":"Tozer","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102045_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/00365521.2019.1600014","article-title":"Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients","volume":"54","author":"Strik","year":"2019","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102045_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ecco-jcc\/jjab168","article-title":"Fibrosis and MAGNIFI-CD activity index at magnetic resonance imaging to predict treatment outcome in perianal fistulizing crohn's disease patients","volume":"16","author":"van Rijn","year":"2022","journal-title":"Journal of Crohn's & colitis"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102045_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MEG.0000000000001561","article-title":"Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease","volume":"32","author":"Plevris","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102045_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0272989X03256005","article-title":"Validation of a decision regret scale","volume":"23","author":"Brehaut","year":"2003","journal-title":"Med Decis Making"},{"issue":"21","key":"10.1016\/j.eclinm.2023.102045_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23210","article-title":"Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT","volume":"23","author":"Jayne","year":"2019","journal-title":"Health Technol Assess"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102045_bib10","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/ajg.2009.509","article-title":"Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas","volume":"104","author":"Ng","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102045_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ecco-jcc\/jjz181","article-title":"Ligation of the intersphincteric fistula tract and endorectal advancement flap for high perianal fistulas in crohn's disease: a retrospective cohort study","volume":"14","author":"van Praag","year":"2020","journal-title":"Journal of Crohn's & colitis"},{"issue":"10051","key":"10.1016\/j.eclinm.2023.102045_bib12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102045_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","article-title":"European evidence-based consensus on the diagnosis and management of crohn's disease 2016: Part 2: surgical management and special situations","volume":"11","author":"Gionchetti","year":"2017","journal-title":"Journal of Crohn's & colitis"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102045_bib14","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102045_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clinimag.2019.10.007","article-title":"Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease","volume":"59","author":"van Rijn","year":"2020","journal-title":"Clin Imag"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102045_bib16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/apt.12906","article-title":"Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease","volume":"40","author":"Yassin","year":"2014","journal-title":"Aliment Pharmacol Therapeutics"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102045_bib17","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.cgh.2018.01.030","article-title":"Efficacy of medical therapies for fistulizing crohn's disease: systematic review and meta-analysis","volume":"16","author":"Lee","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102045_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2036.2010.04509.x","article-title":"Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study","volume":"33","author":"Schreiber","year":"2011","journal-title":"Aliment Pharmacol Therapeutics"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102045_bib19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.eclinm.2023.102045_bib20","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3748\/wjg.v28.i23.2597","article-title":"Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease","volume":"28","author":"Gu","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102045_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9270(02)05909-9","article-title":"Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease","volume":"98","author":"Van Assche","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102045_bib22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cgh.2015.10.025","article-title":"Optimizing anti-TNF-\u03b1 therapy: serum levels of infliximab and adalimumab are associated with mucosal healing in patients with inflammatory bowel diseases","volume":"14","author":"Ungar","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102045_bib23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/apt.13970","article-title":"Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease","volume":"45","author":"Yarur","year":"2017","journal-title":"Aliment Pharmacol Therapeutics"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102045_bib24","first-page":"549","article-title":"Association of induction infliximab levels with clinical response in perianal crohn's disease","volume":"11","author":"Davidov","year":"2017","journal-title":"Journal of Crohn's & colitis"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102045_bib25","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/ibd.21555","article-title":"Potential role for SNAIL family transcription factors in the etiology of Crohn's disease-associated fistulae","volume":"17","author":"Scharl","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102045_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ibd\/izy217","article-title":"Higher postinduction infliximab serum trough levels are associated with healing of fistulizing perianal crohn's disease in children","volume":"25","author":"El-Matary","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102045_bib27","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.cgh.2021.07.053","article-title":"Higher anti-tumor necrosis factor-\u03b1 levels correlate with improved radiologic outcomes in crohn's perianal fistulas","volume":"20","author":"De Gregorio","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102045_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/ecco-jcc\/jju026","article-title":"High-dose infliximab therapy in Crohn's disease: clinical experience, safety, and efficacy","volume":"9","author":"Hendler","year":"2015","journal-title":"J\u00a0Crohn's Colitis"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102045_bib29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/ecco-jcc\/jjv116","article-title":"Serum concentration of anti-TNF antibodies, adverse effects and quality of life in patients with inflammatory bowel disease in remission on maintenance treatment","volume":"9","author":"Brandse","year":"2015","journal-title":"Journal of Crohn's & colitis"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102045_bib30","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","article-title":"Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis","volume":"14","author":"Bonovas","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102045_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40261-016-0459-y","article-title":"Safety profile of biologic drugs in the treatment of inflammatory bowel diseases: a systematic review and network meta-analysis of randomized controlled trials","volume":"37","author":"Mo\u0107ko","year":"2017","journal-title":"Clin Drug Invest"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102045_bib32","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT\u2122 registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102045_bib33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/MIB.0000000000000315","article-title":"Guidelines for the multidisciplinary management of Crohn's perianal fistulas: summary statement","volume":"21","author":"Schwartz","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl 3","key":"10.1016\/j.eclinm.2023.102045_bib34","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023002225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023002225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:19:05Z","timestamp":1762899545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023002225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":34,"alternative-id":["S2589537023002225"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102045","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy alone for Crohn's perianal fistulas (PISA-II): long-term outcomes of an international, multicentre patient preference, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102045"}}